ATE168131T1 - T-cadherin-bindungsmolekül - Google Patents

T-cadherin-bindungsmolekül

Info

Publication number
ATE168131T1
ATE168131T1 AT92900808T AT92900808T ATE168131T1 AT E168131 T1 ATE168131 T1 AT E168131T1 AT 92900808 T AT92900808 T AT 92900808T AT 92900808 T AT92900808 T AT 92900808T AT E168131 T1 ATE168131 T1 AT E168131T1
Authority
AT
Austria
Prior art keywords
cadherin
binding molecule
various forms
polypeptides
detecting
Prior art date
Application number
AT92900808T
Other languages
English (en)
Inventor
Barbara Ranscht
Original Assignee
Jolla Cancer Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jolla Cancer Res Found filed Critical Jolla Cancer Res Found
Application granted granted Critical
Publication of ATE168131T1 publication Critical patent/ATE168131T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Adhesives Or Adhesive Processes (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT92900808T 1990-10-30 1991-10-30 T-cadherin-bindungsmolekül ATE168131T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60729390A 1990-10-30 1990-10-30

Publications (1)

Publication Number Publication Date
ATE168131T1 true ATE168131T1 (de) 1998-07-15

Family

ID=24431648

Family Applications (1)

Application Number Title Priority Date Filing Date
AT92900808T ATE168131T1 (de) 1990-10-30 1991-10-30 T-cadherin-bindungsmolekül

Country Status (8)

Country Link
US (4) US5585351A (de)
EP (1) EP0619841B1 (de)
JP (1) JPH06505962A (de)
AT (1) ATE168131T1 (de)
AU (1) AU669474B2 (de)
CA (1) CA2095115A1 (de)
DE (1) DE69129760T2 (de)
WO (1) WO1992008731A2 (de)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0619841B1 (de) * 1990-10-30 1998-07-08 La Jolla Cancer Research Foundation T-cadherin-bindungsmolekül
US5597725A (en) * 1992-04-17 1997-01-28 Doheny Eye Institute Cadherin-specific antibodies and hybridoma cell lines
US5646250A (en) * 1992-04-17 1997-07-08 Doheny Eye Institute Cadherin polypeptides
JPH07500019A (ja) 1992-04-17 1995-01-05 ドーニー　アイ　インスティテュート カドヘリン物質および方法
US5643781A (en) * 1992-12-29 1997-07-01 Doheny Eye Institute DNA encoding protocadherin-42
US5798224A (en) * 1992-12-29 1998-08-25 Doheny Eye Institute Nucleic acids encoding protocadherin
US20040006011A1 (en) * 1996-07-12 2004-01-08 Gour Barbara J. Peptidomimetic modulators of cell adhesion
US6207639B1 (en) 1996-07-12 2001-03-27 Mcgill University Compounds and methods for modulating neurite outgrowth
US6417325B1 (en) 1996-07-12 2002-07-09 Mcgill University Compounds and methods for cancer therapy
US6333307B1 (en) 1996-07-12 2001-12-25 Mcgill University Compounds and method for modulating neurite outgrowth
US6169071B1 (en) 1996-07-12 2001-01-02 Mcgill University Compounds and methods for modulating cell adhesion
US6610821B1 (en) 1996-07-12 2003-08-26 Mcgill University Compounds and methods for modulating endothelial cell adhesion
US6562786B1 (en) 1996-07-12 2003-05-13 Mcgill University Compounds and methods for modulating apoptosis
US7122623B2 (en) * 1996-07-12 2006-10-17 Adherex Technologies, Inc. Compounds and methods for modulating cell adhesion
US6346512B1 (en) 1996-07-12 2002-02-12 Mcgill University Compounds and methods for modulating cell adhesion
US6465427B1 (en) 1996-07-12 2002-10-15 Mcgill University Compounds and methods for modulating cell adhesion
JP2001500475A (ja) * 1996-07-12 2001-01-16 マクギル ユニバーシティ 細胞接着を調節するための化合物および方法
US6203788B1 (en) 1997-09-29 2001-03-20 Adherex Inc. Compounds and methods for regulating cell adhesion
US7481999B2 (en) * 1998-05-05 2009-01-27 Adherex Technologies, Inc. Compounds and methods for modulating OB-cadherin-mediated function
US6680175B2 (en) * 1998-05-05 2004-01-20 Adherex Technologies, Inc. Methods for diagnosing and evaluating cancer
US6638911B1 (en) 1998-05-05 2003-10-28 Adherex Technologies Inc. Compounds and methods for modulating desmosomal cadherin-mediated functions
US20050203025A1 (en) * 1998-05-05 2005-09-15 Adherex Technologies, Inc. Compounds and methods for modulating nonclassical cadherin-mediated functions
US6472367B1 (en) 1998-05-05 2002-10-29 Adherex Technologies, Inc. Compounds and methods for modulating OB-cadherin mediated cell adhesion
US6277824B1 (en) * 1998-07-10 2001-08-21 Adherex Technologies Compounds and methods for modulating adhesion molecule function
US7041807B1 (en) 1999-06-23 2006-05-09 Caprion Pharmaceuticals, Inc. Antibodies to a YYX epitope of a mammalian prion protein
AU2001249064A1 (en) * 2000-02-22 2001-09-03 Mount Sinai School Of Medicine Of New York University N-cadherin modulated migration, invasion, and metastasis
US20040072236A1 (en) 2002-09-27 2004-04-15 Neil Cashman PrPSc -interacting molecules and uses thereof
AU2003298475A1 (en) * 2002-11-14 2004-06-18 Adherex Technologies, Inc. Compounds and methods for modulating desmosomal and atypical cadherin-mediated cell adhesion
WO2004096272A2 (en) * 2003-04-29 2004-11-11 Cytos Biotechnology Ag Methods and compositions for modulating the interaction between adiponectin and its receptor
US20090123471A1 (en) * 2004-10-29 2009-05-14 Cytos Biotechnology Ag T-Cadherin antigen arrays and uses thereof
NZ562234A (en) * 2005-04-26 2009-09-25 Pfizer P-cadherin antibodies
US20060292159A1 (en) * 2005-06-08 2006-12-28 Ranscht Barbara E Methods for the inhibition of neovascularization and cancer metastasis
US9534058B2 (en) 2012-02-08 2017-01-03 Abbvie Stemcentrx Llc Anti-CD324 monoclonal antibodies and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0619841B1 (de) * 1990-10-30 1998-07-08 La Jolla Cancer Research Foundation T-cadherin-bindungsmolekül

Also Published As

Publication number Publication date
US5863804A (en) 1999-01-26
EP0619841B1 (de) 1998-07-08
EP0619841A1 (de) 1994-10-19
US5585351A (en) 1996-12-17
CA2095115A1 (en) 1992-05-01
DE69129760D1 (de) 1998-08-13
DE69129760T2 (de) 1999-03-25
EP0619841A4 (de) 1994-05-17
AU669474B2 (en) 1996-06-13
US5811518A (en) 1998-09-22
WO1992008731A2 (en) 1992-05-29
JPH06505962A (ja) 1994-07-07
AU8953191A (en) 1992-06-11
US5837525A (en) 1998-11-17
WO1992008731A3 (en) 1992-06-25

Similar Documents

Publication Publication Date Title
DE69129760D1 (de) T-cadherin-bindungsmolekül
AU641568B2 (en) Polypeptide,DNA fragment encoding the same and process for producing the same, and enzyme inhibition process, drug composition and methods of treating using the same
DE60030769D1 (de) Verfahren zur behandlung von entzündungen
ATE255635T1 (de) Polypeptid, fähig zur inhibierung der bindung zwischen menschliches il-6 und dessen rezeptor
ATE159429T1 (de) Methode zum überbringen von agenzien an zielzellen
NO963785L (no) Fremgangsmåte for behandling av 5HT2B-reseptor-relaterte betingelser
OA06717A (fr) Séquences d'ADN, molécule d'ADN recombinantes et procédé pour la production de polypeptides humains semblables aux interférons.
FI941572A0 (fi) Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä
DK0784683T3 (da) TIE-2-ligander, fremgangsmåder til dannelse af disse og anvendelser deraf
DE3689734D1 (de) Gereinigter immunoglobulinbezüglicher Faktor, monoklonale Antikörper, Hybridoma-Zellinien, Verfahren und Verwendungen.
DE68925226D1 (de) Monoklonale Antikörper
FI92603B (fi) Mikrobinen menetelmä syklosporiinien valmistamiseksi
EP0215625A3 (en) Protein recovery
DE69407272D1 (de) Verfahren zum reinigen von 20 cs)-camptothecin
ATE86121T1 (de) Monoklonale antikoerper und verfahren zum nachweis von pilzpathogenen.
DK0572688T3 (da) Peptider, med organ-beskyttende aktivitet, fremgangsmåde til deres fremstilling og deres anvendelse ved terapi
FI883526A7 (fi) Parkitusapuaine, sen käyttö ja menetelmä nahan parkitsemiseksi
FI964997L (fi) Menetelmä tuumorisolun kasvun estämiseksi käyttäen syndekaani-1:n solun ulkoista osaa
AU1971295A (en) Humanized monoclonal antibodies against human interleukin-4
DE69615843D1 (de) Il-8 antagonisten zur behandlung von asthma
AU3498795A (en) Method of blocking the sec receptor
DE3583265D1 (de) Tumortherapeutikum und verfahren zu seiner herstellung.
EP0369816A3 (de) Gegen menschliches polymorphes epitheliales Muzin spezifische monoklonale Antikörper
FR2679235B1 (fr) Methode de purification des aminoacides, des acides nucleiques et de leurs derives.
DE69018484D1 (de) Rohrschlange zum ausschwemmen von bodensatz.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties